Skip to main content
letter
. 2022 Nov 15;23:311. doi: 10.1186/s12931-022-02237-w

Table 1.

Characteristics of COPDGene study participants

Demographic (mean ± SD) Mild to very Severe COPD (GOLD 1–4)
(N = 4248)
Smoking controls
No COPD (GOLD 0)
(N = 4116)
Non-smoking controls
(N = 104)
Age (years) 63.1 ± 8.6 56.7 ± 8.4 62.2 ± 9.4
Percent Male N (%) 2,393 (56.3) 2,194 (53.3) 32 (30.8)
Race N (%)
 Non-Hispanic White 3,296 (77.6) 2,422 (58.8) 97 (93.3)
 African American 952 (22.4) 1,694 (41.2) 7 (6.7)
Pack Years 51.4 ± 27.0 37.3 ± 20.2
Current Smoker N (%) 1,833 (43.1) 2,441 (59.3)
BMI (kg/m2) N (%)
 Underweight (< 18.5) 106 (2.5) 27 (0.66) 1 (0.96)
 Healthy Weight (18.5 ≤ BMI < 25) 1,369 (32.2) 1,029 (25.0) 31 (29.8)
 Overweight (25 ≤ BMI < 30) 1,435 (33.8) 1,530 (37.2) 38 (36.5)
 Obese (BMI ≥ 30) 1,338 (31.5) 1,530 (37.2) 34 (32.7)
Inhaled Corticosteroid Use N (%) 1,880 (45.0) 224 (5.5) 0 (0)
Severe Exacerbations N (%) 818 (19.3) 174 (4.2) 0 (0)
Number of Comorbidities N (%)
 0 1,374 (32.4) 1,965 (47.8) 49 (47.1)
 1–2 2,325 (54.8) 1,883 (45.8) 51 (49.0)
 3 +  545 (12.8) 266 (6.5) 4 (3.8)
Percent Emphysema 11.7 ± 12.3 2.0 ± 2.5 1.7 ± 2.2
FEV1 Percent Predicted 57.6 ± 22.7 97.4 ± 11.4 102.7 ± 13.6
Six Minute Walking Distance (m) 377.2 ± 124.5 455.7 ± 106.3 513.0 ± 100.0

BMI, body mass index; COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in 1 s; SD, standard deviation